Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

IBBQ vs PBE: which is really different?

IBBQ and PBE hold 38% of their weight in the same names, and IBBQ returned more over the year.

Invesco Nasdaq Biotechnology ETF and Invesco Biotechnology & Genome ETF.

38.6%IBBQ in the S&P 500
30.0%PBE in the S&P 500
+44.6%IBBQ total return, 1 year
+36.2%PBE total return, 1 year

ETFIQ Off-Index Score: IBBQ scores higher

How much of it is not the index it is sold as an alternative to?

IBBQ 61.7PBE 61.70.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

IBBQ61% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
39%61%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 45% of the fund · 256 holdings filed Sep 19, 2026 · Nasdaq-100: 33% in39%61%in the S&P 500outside the S&P 500active share 99% · top ten 45% of the fund
PBE70% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
30%70%in the S&P 500of its weight outside the S&P 500active share 99% · top ten 47% of the fund · 33 holdings filed Sep 19, 2026 · Nasdaq-100: 20% in30%70%inoutside the S&P 500active share 99% · top ten 47% of the fund

38% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, IBBQ and PBE hold 38% of their money in the same securities at the same weight.

Positions IBBQ and PBE both hold, largest shared weight first
HoldingIBBQPBE
Gilead Sciences Inc7.89%5.27%
Regeneron Pharmaceuticals Inc5.42%4.89%
Vertex Pharmaceuticals Inc7.98%4.77%
Amgen Inc8.05%4.53%
Moderna Inc4.10%2.75%
Illumina Inc2.43%5.53%
Biogen Inc2.13%5.07%
Royalty Pharma PLC1.74%4.88%
Incyte Corp1.68%2.73%
United Therapeutics Corp1.41%2.70%
Neurocrine Biosciences Inc0.98%2.70%
Exelixis Inc0.98%2.91%
Only in each
Only in IBBQOnly in PBE
Revolution Medicines Inc 2.72%Natera Inc 5.70%
Alnylam Pharmaceuticals Inc 2.14%TG Therapeutics Inc 2.91%
Roivant Sciences Ltd 1.92%QIAGEN NV 2.81%
Argenx SE 1.83%Repligen Corp 2.76%
Insmed Inc 1.74%
Guardant Health Inc 1.59%
Viatris Inc 1.32%
Medpace Holdings Inc 1.17%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 19, 2026.

Performance, window by window

IBBQ and PBE over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
IBBQPBEIBBQPBEIBBQPBE
3 months+15.8%+13.2%+13.6 pts+11.0 pts+18.3 pts+15.7 pts
6 months+24.9%+25.9%+6.9 pts+7.8 pts+0.7 pts+1.6 pts
1 year+44.6%+36.2%+28.0 pts+19.6 pts+22.8 pts+14.4 pts
3 years+76.7%+65.0%−1.7 pts−13.4 pts−21.5 pts−33.1 pts
Since launch+42.0%+492.4%−51.2 pts−311.1 pts−76.1 pts−1197.8 pts
Open the live comparison on ETFIQ
IBBQ and PBE on the same fields, as of Sep 18, 2026. Source: ETFIQ.
IBBQ
Invesco Nasdaq Biotechnology ETF
Holds 256 stocks in biotech, 39% of its weight in S&P 500 companies
PBE
Invesco Biotechnology & Genome ETF
Holds 33 stocks in biotech, 30% of its weight in S&P 500 companies
IssuerInvescoInvesco
ThemeBiotechBiotech
In the S&P 50038.6%30.0%
Active share vs the S&P 50099.0%99.0%
In the Nasdaq-10033.2%19.5%
Holdings25633
Top ten, share of the fund44.8%46.7%
Expense ratio0.19%0.59%
Fee for the differing part0.19%0.60%
Total return, 1 year+44.6%+36.2%
vs the S&P 500+28.0 pts+19.6 pts
vs the Nasdaq-100+22.8 pts+14.4 pts
Below its high−5.8%−3.9%
Net assets$96m$414m

IBBQ in plain words

By weight, 39% of IBBQ's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 45% of the fund across 256 positions, as published by its issuer for Sep 19, 2026. Over the year to Sep 18, 2026 the fund returned +44.6% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 28.0 pts. It sits 5.8% below its all-time high of Aug 19, 2026.

PBE in plain words

By weight, 30% of PBE's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 47% of the fund across 33 positions, as published by its issuer for Sep 19, 2026. Over the year to Sep 18, 2026 the fund returned +36.2% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 19.6 pts.

Questions people ask

Do IBBQ and PBE hold the same stocks?
By their latest filings, 38% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, IBBQ or PBE?
IBBQ has 39% of its weight in S&P 500 names and PBE has 30%, so IBBQ differs more from the index.
Which is cheaper, IBBQ or PBE?
IBBQ charges 0.19% a year and PBE charges 0.59%, so IBBQ is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

IBBQ against PBE, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, IBBQ against PBE, data as of Sep 18, 2026. https://etfiq.com/compare/themes/ibbq-vs-pbe Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources